Abstract
To study the relationship between blood pressure and oxidative stress in leukocytes, the effect of benidipine on these variables was compared with that of a placebo. Hypertensive patients were randomly assigned benidipine 4 mg (n=40) or placebo (n=40), and treated for 6 months. Oxidative stress in polymorphonuclear cells (PMNs) was measured by gated flow cytometry. There was a significant relationship between systolic or diastolic arterial pressure and reactive oxygen species (ROS) formation by PMNs in the benidipine group (r=0.61, p<0.01) and in the placebo group (r=0.58, p<0.01). After administration of 4 mg benidipine, ROS formation by PMNs fell by 32 arbitrary units (n=40, p<0.01). After administration of placebo, ROS formation by PMNs decreased by 0.6 arbitrary units (n=40, p=0.31) (p<0.01 for differing treatment effects). There was a significant relationship between the decrease in systolic arterial pressure and the decrease in ROS formation by PMNs in the benidipine group (r=0.52, p<0.01), but not in the placebo group (r=-0.08, p=0.61). There was also a significant relationship between the decrease in diastolic arterial pressure and decrease in ROS formation by PMNs in the benidipine group (r=0.65, p<0.01) but not in the placebo group (r=-0.09, p=0.59). In hypertensive patients, we observed a significant relationship between systolic or diastolic blood pressure and ROS formation by PMNs, and found that benidipine decreased oxidative stress in PMNs of hypertensive patients, at least in part by decreasing blood pressure.
Similar content being viewed by others
Article PDF
References
Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneous hypertensive rats. Hypertension 2000; 35: 1055–1061.
Parik T, Allikmets K, Teesalu R, Zilmer M : Oxidative stress and hyperinsulinaemia in essential hypertension: different facets of increased risk. J Hypertens 1996; 14: 407–410.
Alexander RW : Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155–161.
Tulenko TN, Sumner AE, Chen M, Huang Y, Laury-Kleintop L, Ferdinand FD : The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection. Am Heart J 2001; 141 ( Suppl): S1–S11.
Pitt B, Byington RP, Furberg CD, et al: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503–1510.
Hernandez RH, Armas-Hernandez MJ, Velasco M, Israili ZH, Armas-Padilla MC : Calcium antagonists and atherosclerosis protection in hypertension. Am J Ther 2003; 10: 409–414.
Napoli C, Salomone S, Godfraind T, et al: 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 1999; 30: 1907–1915.
Smedly LA, Tonnesen MG, Sandhaus RA, et al: Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77: 1233–1243.
Weiss SJ : Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–376.
Naruko T, Ueda M, Haze K, et al: Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894–2900.
Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J : Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation 1999; 99: 1370–1378.
Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J : Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D1-like receptors. Circulation 2000; 101: 2302–2308.
Yasunari K, Maeda M, Nakamura M, Yoshikawa J : Oxidative stress in leukocytes is a possible link between hypertension, diabetes, C-reacting protein. Hypertension 2002; 39: 777–780.
Yasunari K, Maeda K, Nakamura M, Yoshikawa J : Carvedilol inhibits pressure-induced increase in oxidative stress in coronary smooth muscle cells. Hypertens Res 2002; 25: 419–425.
Ohmori M, Kitoh Y, Kawaguchi A, Harada K, Sugimoto K, Fujimura A : Enhanced neutrophil superoxide anion production and its modification by beraprost sodium in spontaneously hypertensive rats. Am J Hypertens 2001; 14: 722–728.
Maeda K, Yasunari K, Sato EF, Yoshikawa J, Inoue M : Activation of protein kinase C and nicotinamide adenine dinucleotide phosphate oxidase in leukocytes of spontaneously hypertensive rats. Hypertens Res 2003; 26: 999–1006.
Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J, Asada A : Carvedilol inhibits oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 2004; 116: 460–465.
Sanidas D, Garnham A, Mian R : Hypoxia-induced chemiluminescence in human leukocytes: the role of Ca2+. Eur J Pharmacol 2002: 453: 183–187.
Yao K, Ina Y, Sonoda R, Nagashima K, Ohmori K, Ohno T : Protective effects of benidipine on hydrogen peroxide-induced injury in rat isolated hearts. J Pharm Pharmacol 2003; 55: 109–114.
Ito H, Takemori K, Suzuki T : Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens 2001; 19: 591–597.
Temelkova-Kurktschiev T, Koeher T, Henkel E, Hanefeld M : Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population of diabetes. Cardiovasc Res 2002; 56: 277.
Kristal B, Shurtz-Swirski R, Chezar J, Manaster J, Levy R : Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 1998; 11: 921–928.
Tuomilehto J, Rastenyte D, Birkenhager WH, et al: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340: 677–684.
Hansson L, Zanchetti A, Carruthers SG, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet 1998; 351: 1755–1762.
Julius S, Kjeldsen SE, Weber MA, et al, for the VALUE Trial Group: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004; 363: 2022–2031.
Yui Y, Sumiyoshi T, Kodama K, et al: Comparison of nifefipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. Hypertens Res 2004: 27: 181–191.
Para MG, Paolini G, Paroni R, et al: Myocardial protection with and without leukocyte depletion: a comparative study on the oxidative stress. Eur J Cardiothorac Surg 1995; 9: 701–706.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yasunari, K., Maeda, K., Nakamura, M. et al. Benidipine, a Long-Acting Calcium Channel Blocker, Inhibits Oxidative Stress in Polymorphonuclear Cells in Patients with Essential Hypertension. Hypertens Res 28, 107–112 (2005). https://doi.org/10.1291/hypres.28.107
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.28.107
Keywords
This article is cited by
-
Lercanidipine Effect on Polymorphonuclear Leukocyte-Related Inflammation and Insulin Resistance in Essential Hypertension Patients
Cardiology and Therapy (2012)
-
Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea
Sleep and Breathing (2011)
